Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate Versus Topiramate in Migraine
NCT06248931Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- May 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valproic acid, topiramate in migraine, sponsored by Kafrelsheikh University. Started May 2022; status: completed.
02
Drugs
valproic acidtopiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT06248931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06248931.